Cargando…

Representation and Outcomes of Individuals With Schizophrenia Seen in Everyday Practice Who Are Ineligible for Randomized Clinical Trials

IMPORTANCE: Most evidence about efficacy and safety of antipsychotics in schizophrenia spectrum disorders relies on randomized clinical trials (RCTs). However, owing to their strict eligibility criteria, RCTs represent only a part of the real-world population (ie, unselected patients seen in everyda...

Descripción completa

Detalles Bibliográficos
Autores principales:	Taipale, Heidi, Schneider-Thoma, Johannes, Pinzón-Espinosa, Justo, Radua, Joaquim, Efthimiou, Orestis, Vinkers, Christiaan H., Mittendorfer-Rutz, Ellenor, Cardoner, Narcís, Pintor, Luis, Tanskanen, Antti, Tomlinson, Anneka, Fusar-Poli, Paolo, Cipriani, Andrea, Vieta, Eduard, Leucht, Stefan, Tiihonen, Jari, Luykx, Jurjen J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2022
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8792792/ https://www.ncbi.nlm.nih.gov/pubmed/35080618 http://dx.doi.org/10.1001/jamapsychiatry.2021.3990

Ejemplares similares

Morbidity and mortality in schizophrenia with comorbid substance use disorders
por: Lähteenvuo, Markku, et al.
Publicado: (2021)

S210. COMPARATIVE EFFECTIVENESS OF ANTIPSYCHOTICS FOR RISK OF ATTEMPTED OR COMPLETED SUICIDE AMONG PERSONS WITH SCHIZOPHRENIA
por: Taipale, Heidi, et al.
Publicado: (2020)

T208. EFFECTIVENESS OF PHARMACOLOGICAL THERAPIES FOR DELUSIONAL DISORDER
por: Lähteenvuo, Markku, et al.
Publicado: (2020)

Comparative Effectiveness of Antipsychotics for Risk of Attempted or Completed Suicide Among Persons With Schizophrenia
por: Taipale, Heidi, et al.
Publicado: (2020)

Real‐world effectiveness of pharmacological treatments of alcohol use disorders in a Swedish nation‐wide cohort of 125 556 patients
por: Heikkinen, Milja, et al.
Publicado: (2021)

Long-Term Real-World Effectiveness of Pharmacotherapies for Schizoaffective Disorder
por: Lintunen, Jonne, et al.
Publicado: (2021)

Real‐world effectiveness of pharmacological treatments of opioid use disorder in a national cohort
por: Heikkinen, Milja, et al.
Publicado: (2022)

Association of Pharmacological Treatments and Hospitalization and Death in Individuals With Amphetamine Use Disorders in a Swedish Nationwide Cohort of 13 965 Patients
por: Heikkinen, Milja, et al.
Publicado: (2022)

Comparative Effectiveness of Pharmacotherapies for the Risk of Attempted or Completed Suicide Among Persons With Borderline Personality Disorder
por: Lieslehto, Johannes, et al.
Publicado: (2023)

Morbidity and mortality in schizophrenia with comorbid substance use disorders in Finland and Sweden
por: Lähteenvuo, M., et al.
Publicado: (2021)

Effectiveness of antipsychotics in schizophrenia with comorbid substance use disorder
por: Lähteenvuo, M., et al.
Publicado: (2021)

Optimal Doses of Specific Antipsychotics for Relapse Prevention in a Nationwide Cohort of Patients with Schizophrenia
por: Taipale, Heidi, et al.
Publicado: (2022)

In the aftermath of clozapine discontinuation: comparative effectiveness and safety of antipsychotics in patients with schizophrenia who discontinue clozapine
por: Luykx, Jurjen J., et al.
Publicado: (2020)

Risk and risk factors for disability pension among patients with treatment resistant depression– a matched cohort study
por: Taipale, Heidi, et al.
Publicado: (2020)

Employment among people with schizophrenia or bipolar disorder: A population‐based study using nationwide registers
por: Holm, Minna, et al.
Publicado: (2020)

Health and work disability outcomes in parents of patients with schizophrenia associated with antipsychotic exposure by the offspring
por: Taipale, Heidi, et al.
Publicado: (2020)

Initiation of antidepressant use among refugee and Swedish-born youth after diagnosis of a common mental disorder: findings from the REMAIN study
por: Taipale, Heidi, et al.
Publicado: (2020)

Patient factors associated with receipt of psychological and pharmacological treatments among individuals with common mental disorders in a Swedish primary care setting
por: Cullen, Alexis E., et al.
Publicado: (2023)

Associations between psychiatric disorders, COVID-19 testing probability and COVID-19 testing results: findings from a population-based study
por: van der Meer, Dennis, et al.
Publicado: (2020)

Associations between psychiatric disorders, COVID-19 testing probability and COVID-19 testing results: findings from a population-based study – ERRATUM
por: van der Meer, Dennis, et al.
Publicado: (2020)

Labour market marginalisation in young adults diagnosed with attention-deficit hyperactivity disorder (ADHD): a population-based longitudinal cohort study in Sweden
por: Helgesson, Magnus, et al.
Publicado: (2023)

Association of Socio-Demographic Factors, Sick-Leave and Health Care Patterns with the Risk of Being Granted a Disability Pension among Psychiatric Outpatients with Depression
por: Mittendorfer-Rutz, Ellenor, et al.
Publicado: (2014)

Risk Factors for Disability Pension among Young Adults Diagnosed with Attention-deficit Hyperactivity Disorder (ADHD) in Adulthood
por: Chen, Lingjing, et al.
Publicado: (2021)

Occupational Branch and Labor Market Marginalization among Young Employees with Adult Onset of Attention Deficit Hyperactivity Disorder—A Population-Based Matched Cohort Study
por: Gémes, Katalin, et al.
Publicado: (2022)

Antipsychotic treatment patterns in refugees and their Swedish-born peers with first-episode non-affective psychosis: findings from the REMAIN study
por: Spaton Goppers, Julia, et al.
Publicado: (2023)

The role of sociodemographic and clinical factors in the initiation and discontinuation of attention deficit hyperactivity disorder medication among young adults in Sweden
por: Gémes, Katalin, et al.
Publicado: (2023)

Sustainable labour market participation among working young adults with diagnosed attention deficit/hyperactivity disorder (ADHD)
por: Helgesson, Magnus, et al.
Publicado: (2023)

Trajectories of antidepressant medication use in individuals before and after being granted disability pension due to common mental disorders- a nationwide register-based study
por: Rahman, Syed, et al.
Publicado: (2018)

Selective outcome reporting across psychopharmacotherapy randomized controlled trials
por: Lancee, Michelle, et al.
Publicado: (2021)

Persistence of Antipsychotic Use After Clozapine Discontinuation: A Real‐World Study Across Antipsychotics
por: Stam, Noraly, et al.
Publicado: (2020)

Socio-economic factors associated with the 1‑year prevalence of severe pain and pain-related sickness absence in the Austrian population
por: Mittendorfer-Rutz, Ellenor, et al.
Publicado: (2017)

Socioeconomic inequalities in treatment of individuals with common mental disorders regarding subsequent development of mental illness
por: Dorner, Thomas E., et al.
Publicado: (2017)

Incidence and Duration of Cumulative Bisphosphonate Use among Community-Dwelling Persons with or without Alzheimer’s Disease
por: Tiihonen, Miia, et al.
Publicado: (2016)

A Life-Course Study on Effects of Parental Markers of Morbidity and Mortality on Offspring’s Suicide Attempt
por: Mittendorfer-Rutz, Ellenor, et al.
Publicado: (2012)

Differences in predictors of permanent work disability between immigrants and natives: a cohort study of adults with sick leave due to common mental disorders
por: Werlen, Laura, et al.
Publicado: (2017)

Sleep disturbance and work-related mental strain: A national prospective cohort study of the prediction of subsequent long-term sickness absence, disability pension and mortality
por: Åkerstedt, Torbjörn, et al.
Publicado: (2020)

Childhood adversity and common mental disorders in young employees in Sweden: is the association affected by early adulthood occupational class?
por: Björkenstam, Emma, et al.
Publicado: (2020)

Risk of suicide attempt and suicide in young adult refugees compared to their Swedish-born peers: a register-based cohort study
por: Geirsdottir, Gerdur, et al.
Publicado: (2021)

Childhood adversity and risk of later labor market marginalization in young employees in Sweden
por: Björkenstam, Emma, et al.
Publicado: (2023)

Safe and informed prescribing of psychotropic medication during the COVID-19 pandemic
por: Luykx, Jurjen J., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_iski8sl4uor4ab043eovggdibr